Zhongnan Medical Journal Press

Home Results

A total of 7 result was found. Results that relate to Pembrolizumab

One case of maculopapule induced by amoxicillin after pembrolizumab treatment

Published on Chinese Journal of Pharmacoepidemiology 2023,32(1):95-98.
5018 times 3262 times

Jing GONG Xiao-Lin CHEN Xue-Li LIU Jun YANG

Pembrolizumab Amoxicillin Maculopapular drug eruption Immune activation
Details
Case report and literature analysis of hypothyroidism induced by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(2):227-232.
5821 times 3355 times

Fei-Long TAN Hong-Ying XIA Zhong-Juan WANG Li DING Li-Na YOU Li ZHOU Jian JIN

Pembrolizumab Immune checkpoint inhibitors Hypothyroidism Adverse drug reaction
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1311-1315.
3779 times 1044 times

Jin-Jin ZOU Ji-Liang ZHANG Ni LI Ding-Yi LIU

Pembrolizumab Lung squamous cell carcinoma Severe immune-related ulcerative colitis Adverse drug reactions
Details
A case of severe immune liver injury caused by pembrolizumab and rechallenge

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):212-217.
3812 times 1099 times

LIU Min YANG Limei YIN Yue ZHAO Bingqing

Pembrolizumab Immune related liver injury Rechallenge of immunotherapy
Details
Cost-utility analysis of pembrolizumab combined with chemotherapy for advanced malignant pleural mesothelioma

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1107-1114.
4111 times 795 times

HU Yunjia ZOU Keqing HOU Yanhong

Pembrolizumab Chemotherapy Advanced malignant pleural mesothelioma Partitioned survival model Cost-utility analysis Pharmacoeconomic evaluation
Details
One case of anaphylaxis caused by pembrolizumab injection

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1196-1200.
3598 times 664 times

HUANG Shuzhen CHEN Xiongjian

Pembrolizumab Anaphylaxis Adverse drug reaction
Details
A case of toxic epidermal necrolysis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1314-1319.
4041 times 792 times

HUANG Lingling LI Xialin HUANG Guangyao LUO Peng WANG Weimin WANG Junping

Pembrolizumab Lung cancer Toxic epidermal necrolysis Adverse drug reaction
Details